Ovarian Cancer Treatment Drugs Markets in China

Publisher Name :
Date: 12-Mar-2018
No. of pages: 272
Inquire Before Buying

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Ovarian Cancer Treatment Drugs Markets in China

Table of Contents

I. Introduction
Report Scope and Methodology
Executive Summary
II. Business Environment
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. Ovarian Cancer Treatment Drugs Industry Assessments
Ovarian Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producers' Sales Volume and Market Share
Paclitaxel
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-Estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
Lh-Rh
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development
IV. Ovarian Cancer Treatment Drugs Production and Demand
Overview
Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Platinum Anticancer Drugs
Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Endocrine Therapy Drug
Anti-Estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
Lh-Rh
Ovarian Cancer Treatment Drugs Import
Chemotherapeutic Drug
Anthracycline Antibiotics
Fluoropyrimidines
Paclitaxel
Platinum Anticancer Drugs
Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Endocrine Therapy Drug
Anti-Estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
Lh-Rh
Pricing Trend
V. Ovarian Cancer Treatment Drugs Market Outlook
Ovarian Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician VIsits
VI. Market Entry Channels
China Market Entry Overview
China's Distribution System
Ovarian Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China's Market Entry
Licensing
Franchising
E-Commerce
Trading Companies and Local Agents
Representative offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises
VII. Ovarian Cancer Treatment Drugs Producer Directory
Ovarian Cancer Treatment Drugs Producer Profiles and Directory

List of Tables

I. Introduction
Economic Outlook Summary
II. Business Environment
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. Ovarian Cancer Treatment Drugs Industry Assessments
Chemotherapeutic Drug Sales Volume and Market Share By Drugs Classification
Targeted Therapy Drug Sales Volume and Market Share By Drugs Classification
Endocrine Therapy Drug Sales Volume and Market Share By Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
Major Foreign Investments In China
IV. Ovarian Cancer Treatment Drugs Production and Demand
Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Major Producer and Their Market Share
Chemotherapeutic Drug Sales Volume and Market Share By Drugs Classification
Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Platinum Anticancer Drugs Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share
Targeted Therapy Drug Sales Volume and Market Share By Drugs Classification
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Sales Volume and Market Share By Drugs Classification
Endocrine Therapy Drug Major Producer and Their Market Share
Anti-Estrogens Major Producer and Their Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
Lh-Rh Major Producer and Their Market Share
Ovarian Cancer Treatment Drugs Import
V. Ovarian Cancer Treatment Drugs Market Outlook
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician VIsits

List of Charts

I. Introduction
Ovarian Cancer Treatment Drugs Sales Volume
II. Business Environment
China's Gdp and Growth Rate
Industrial Output By Ownership
China's Imports and Exports
III. Ovarian Cancer Treatment Drugs Industry Assessments
Chemotherapeutic Drug Market Share By Drugs Classification
Targeted Therapy Drug Market Share By Drugs Classification
Endocrine Therapy Drug Market Share By Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume
IV. Ovarian Cancer Treatment Drugs Production and Demand
Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume By Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Platinum Anticancer Drugs Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume By Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume By Drugs Classification
Anti-Estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
Lh-Rh Sales Volume and Market Share
Ovarian Cancer Treatment Drugs Import
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import By Drugs Classification
Paclitaxel Import and Market Share
Anthracycline Antibiotics Import and Market Share
Fluoropyrimidines Import and Market Share
Placlitaxel Anticancer Drugs Import and Market Share
Platinum Anticancer Drugs Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import By Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import By Drugs Classification
Anti-Estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
Lh-Rh Import and Market Share
VI. Marketing Strategies
China's Distribution Channel
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs